Application of new ZnO nanoformulation and Ag/Fe/ZnO nanocomposites as water-based nanofluids to consider in vitro cytotoxic effects against MCF-7 breast cancer cells

Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1769-1777. doi: 10.1080/21691401.2017.1290643. Epub 2017 Feb 20.

Abstract

Novel formulations of nanocomposites derived from ZnO nanoparticles have provided potential biomedical applications as a new strategy for treatment of breast cancer. In this research, two types of ZnO nanomaterials were synthesized by sol-gel hydrothermal process and co-precipitation containing fast quenching and also surface modification methods. The cytotoxic effects on growth of the breast cancer cell lines MCF-7 were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Cell viability of the breast cancer cell line MCF-7 was reduced with increasing ZnO nanofluid concentrations at 48 and 72 h of treatment. The IC50 value of MCF-7 cells after 72 h of treatment with the first product ZnO (a) and second one ZnO

Keywords: Modification of surface; breast cancer cell lines MCF-7; high trapping states; hydrophilic ZnO nanosurface; normal human fibroblast cell MRC-5; synergistic effect; wide bandgap energy.

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Drug Compounding
  • Humans
  • Iron / chemistry*
  • MCF-7 Cells
  • Nanocomposites / chemistry*
  • Nanoparticles / chemistry
  • Silver / chemistry*
  • Water / chemistry*
  • Zinc Oxide / chemistry*

Substances

  • Antineoplastic Agents
  • Water
  • Silver
  • Iron
  • Zinc Oxide